群体免疫
免疫
牧群
人口
接种疫苗
传输(电信)
生物
大流行
2019年冠状病毒病(COVID-19)
免疫学
冠状病毒
医学
环境卫生
免疫系统
疾病
生态学
传染病(医学专业)
计算机科学
内科学
电信
作者
Tom Britton,Frank Ball,Pieter Trapman
出处
期刊:Science
[American Association for the Advancement of Science]
日期:2020-08-14
卷期号:369 (6505): 846-849
被引量:746
标识
DOI:10.1126/science.abc6810
摘要
Heterogeneity and herd immunity In response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), some politicians have been keen to exploit the idea of achieving herd immunity. Countering this possibility are estimates derived from work on historical vaccination studies, which suggest that herd immunity may only be achieved at an unacceptable cost of lives. Because human populations are far from homogeneous, Britton et al. show that by introducing age and activity heterogeneities into population models for SARS-CoV-2, herd immunity can be achieved at a population-wide infection rate of ∼40%, considerably lower than previous estimates. This shift is because transmission and immunity are concentrated among the most active members of a population, who are often younger and less vulnerable. If nonpharmaceutical interventions are very strict, no herd immunity is achieved, and infections will then resurge if they are eased too quickly. Science , this issue p. 846
科研通智能强力驱动
Strongly Powered by AbleSci AI